Macroprolactinaemia in patients with hyperprolactinaemia: Composition of macroprolactin and stability during long-term follow-up

Clinical Endocrinology

Volumn 73, Issue 6, 2010, Pages 792-797

  Hattori, Naoki ^a   Ishihara, Takashi ^b   Saiki, Yasuhiko ^b   Shimatsu, Akira ^c  

^a RITSUMEIKAN UNIVERSITY   (Japan)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; IODINE 125; MACROGOL; MACROPROLACTIN; PROLACTIN; PROLACTIN ANTIBODY; PROTEIN G; UNCLASSIFIED DRUG;

ADULT; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BLOOD SAMPLING; CHEMICAL COMPOSITION; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; HUMAN; HYPERPROLACTINEMIA; MACROPROLACTINEMIA; MAJOR CLINICAL STUDY; MALE; PRECIPITATION; PREDICTION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN STABILITY;

ADULT; AUTOANTIBODIES; FEMALE; HUMANS; HYPERPROLACTINEMIA; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROLACTIN;

EID: 78649235625     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03880.x     Document Type: Article

References (27)

1. Bjøro, T., Mørkrid, L., Wergeland, R., et al. (1995) Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL). Scandinavian Journal of Clinical and Laboratory Investigation, 55, 139 - 147.
2. Fahie-Wilson, M.N., &, Soule, S.G., (1997) Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Annals of Clinical Biochemistry, 34, 252 - 258.
3. Olukoga, A.O., &, Kane, J.W., (1999) Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clinical Endocrinology, 51, 119 - 126.
4. Vallette-Kasic, S., Morange-Ramos, I., Selim, A., et al. (2002) Macroprolactinemia revisited: a study on 106 patients. Journal of Clinical Endocrinology and Metabolism, 87, 581 - 588.
5. Gibney, J., Smith, T.P., &, McKenna, T.J., (2005) Clinical relevance of macroprolactin. Clinical Endocrinology, 62, 633 - 643.
6. Gibney, J., Smith, T.P., &, McKenna, T.J., (2005) The impact on clinical practice of routine screening for macroprolactin. Journal of Clinical Endocrinology and Metabolism, 90, 3927 - 3932. (Pubitemid 41058153)
7. Leslie, H., Courtney, C.H., Bell, P.M., et al. (2001) Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. Journal of Clinical Endocrinology and Metabolism, 86, 2743 - 2746.
8. Hattori, N., Ishihara, T., &, Saiki, Y., (2009) Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers. Clinical Endocrinology, 71, 702 - 708.
9. Glezer, A., Soares, C.R.J., Vieira, J.G., et al. (2006) Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay. Journal of Clinical Endocrinology and Metabolism, 91, 1048 - 1055.
10. Mirannda, A.L., Mondragon, G.C., Leanos, R.R., et al. (2006) Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients. Clinical Endocrinology, 65, 146 - 153.
11. Kavanagh, L., Smith, T.P., &, McKenna, T.J., (2007) Bioactivity of macroprolactin in the Nb2 bioassay may be explained by dissociation yielding bioactive monomeric prolactin. Clinical Endocrinology, 67, 954.
12. Hattori, N., Nakayama, Y., Kitagawa, K., et al. (2008) Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia. Clinical Endocrinology, 68, 72 - 76.
13. Bonhoff, A., Vuille, J.C., Gomez, F., et al. (1995) Identification of macroprolactin in a patient with asymptomatic hyperprolactinemia as a stable PRL-IgG complex. Experimental and Clinical Endocrinology & Diabetes, 103, 252 - 255.
14. Sapin, R., &, Kertesz, G., (2003) Macroprolactin detection by precipitation with protein A-sepharose: a rapid screening method compared with polyethylene glycol precipitation. Clinical Chemistry, 49, 502 - 505.
15. De Schepper, J., Schiettecatte, J., Velkeniers, B., et al. (2003) Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes. European Journal of Endocrinology, 149, 201 - 207.
16. Amadori, P., Dilberis, C., Marcolla, A., et al. (2004) Identification of IgG-immunocomplex macroprolactin with an immunometric "sandwich" system: technical and clinical considerations. Journal of Endocrinological Investigation, 27, 1022 - 1028.
17. Hattori, N., Ishihara, T., Ikekubo, K., et al. (1992) Autoantibody to human prolactin in patients with idiopathic hyperprolactinemia. Journal of Clinical Endocrinology and Metabolism, 75, 1226 - 1229.
18. Hattori, N., Nakayama, Y., Ishihara, T., et al. (2006) Anti-prolactin (PRL) autoantibody binding sites (epitopes) on PRL molecule in macroprolactinaemia. Journal of Endocrinology, 190, 287 - 293.
19. Wright, L.K., Smith, T.P., Gibney, J., et al. (2009) Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients. Clinical Endocrinology, 70, 599 - 605.
20. Hattori, N., (1996) The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies. Journal of Clinical Endocrinology and Metabolism, 81, 586 - 590.
21. Vieira, J.G., Tachibana, T.T., Obara, L.H., et al. (1998) Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinaemia. Clinical Chemistry, 44, 1758 - 1759.
22. Fahie-Wilson, M.N., (1999) Polyethylene glycol precipitation as a screening method for macroprolactinaemia. Clinical Chemistry, 45, 436 - 437.
23. Suliman, A.M., Smithm, T.P., Gibney, J., et al. (2003) Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clinical Chemistry, 49, 1504 - 1509.
24. Hattori, N., &, Inagaki, C., (1997) Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex. Journal of Clinical Endocrinology and Metabolism, 82, 3107 - 3110.
25. Fineberg, S.E., Biegel, A.A., Durr, K.L., et al. (1991) Presence of insulin autoantibodies as regular feature of nondiabetic repertoire of immunity. Diabetes, 40, 1187 - 1193.
26. Benvenga, S., Bartolone, L., Squadrito, S., et al. (1997) Thyroid hormone autoantibodies elicited by diagnostic fine needle biopsy. Journal of Clinical Endocrinology and Metabolism, 82, 4217 - 4223.
27. Wallace, I.R., Satti, N., Courtney, H., et al. (2010) Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant. Journal of Clinical Endocrinology and Metabolism, 95, 3268 - 3271.